201 related articles for article (PubMed ID: 31152553)
1. Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis.
Veselka J; Faber L; Liebregts M; Cooper R; Januska J; Kashtanov M; Dabrowski M; Hansen PR; Seggewiss H; Hansvenclova E; Bundgaard H; Ten Berg J; Stables RH; Jensen MK
Eur Heart J; 2019 Jun; 40(21):1681-1687. PubMed ID: 31152553
[TBL] [Abstract][Full Text] [Related]
2. Alcohol septal ablation in patients with severe septal hypertrophy.
Veselka J; Jensen M; Liebregts M; Cooper RM; Januska J; Kashtanov M; Dabrowski M; Hansen PR; Seggewiss H; Hansvenclova E; Bundgaard H; Ten Berg J; Hilton Stables R; Faber L
Heart; 2020 Mar; 106(6):462-466. PubMed ID: 31471463
[TBL] [Abstract][Full Text] [Related]
3. An assessment of regression of left ventricular hypertrophy following alcohol ablation of the interventricular septum in patients with hypertrophic cardiomyopathy with left ventricular outflow tract obstruction.
Dąbrowski M; Chojnowska L; Małek L; Spiewak M; Kuśmierczyk B; Koziarek J; Klisiewicz A; Miśko J; Witkowski A
Kardiol Pol; 2012; 70(8):782-8. PubMed ID: 22933209
[TBL] [Abstract][Full Text] [Related]
4. Reduction of left ventricular mass, left atrial size, and N-terminal pro-B-type natriuretic peptide level following alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Dąbrowski M; Kukuła K; Kłopotowski M; Bekta P; Śpiewak M; Mazurkiewicz Ł; Tyczyński P; Orczykowski M; Parma R; Witkowski A
Kardiol Pol; 2019; 77(2):181-189. PubMed ID: 30566209
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy.
Liebregts M; Faber L; Jensen MK; Vriesendorp PA; Januska J; Krejci J; Hansen PR; Seggewiss H; Horstkotte D; Adlova R; Bundgaard H; Ten Berg JM; Veselka J
JACC Cardiovasc Interv; 2017 Jun; 10(11):1134-1143. PubMed ID: 28595881
[TBL] [Abstract][Full Text] [Related]
6. Effect of Institutional Experience on Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.
Veselka J; Faber L; Jensen MK; Cooper R; Januska J; Krejci J; Bartel T; Dabrowski M; Hansen PR; Almaas VM; Seggewiss H; Horstkotte D; Adlova R; Bundgaard H; Ten Berg J; Liebregts M
Can J Cardiol; 2018 Jan; 34(1):16-22. PubMed ID: 29275877
[TBL] [Abstract][Full Text] [Related]
7. Chronic phase improvements in electrocardiographic and echocardiographic manifestations of left ventricular hypertrophy after alcohol septal ablation for drug-refractory hypertrophic obstructive cardiomyopathy.
Matsuda J; Kitamura M; Takayama M; Imori Y; Shibuya J; Kubota Y; Sangen H; Nakamura S; Takano H; Asai K; Shimizu W
Heart Vessels; 2018 Mar; 33(3):246-254. PubMed ID: 28965135
[TBL] [Abstract][Full Text] [Related]
8. Predictors of long-term outcome after septal myectomy in symptomatic hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation and residual obstruction.
Zhu C; Tang B; Cui H; Wang S; Xiao M; Chen Z; Meng Y; Zhao S; Song Y; Yu Q; Wang S
J Card Surg; 2019 Jul; 34(7):533-540. PubMed ID: 31111576
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Patients With Hypertrophic Obstructive Cardiomyopathy and Pacemaker Implanted After Alcohol Septal Ablation.
Veselka J; Liebregts M; Cooper R; Faber L; Januska J; Kashtanov M; Tesarkova KH; Hansen PR; Seggewiss H; Shloydo E; Popov K; Hansvenclova E; Bonaventura J; Berg JT; Stables RH; Polakova E
JACC Cardiovasc Interv; 2022 Oct; 15(19):1910-1917. PubMed ID: 36202559
[TBL] [Abstract][Full Text] [Related]
10. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience.
Nogic J; Koh Y; Bak M; Gooley RP; Meredith IT; McCormick LM
Heart Lung Circ; 2018 Dec; 27(12):1446-1453. PubMed ID: 29129561
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in the Young and the Elderly.
Liebregts M; Steggerda RC; Vriesendorp PA; van Velzen H; Schinkel AF; Willems R; van Cleemput J; van den Berg MP; Michels M; ten Berg JM
JACC Cardiovasc Interv; 2016 Mar; 9(5):463-9. PubMed ID: 26965935
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of hypertrophic obstructive cardiomyopathy patients undergoing alcohol septal ablation with a standard 3 mL dose of ethanol: Focus on long-term safety.
Kashtanov MG; Rzhannikova AD; Chernyshev SD; Kardapoltsev LV; Idov EM; Berdnikov SV; Kochmasheva VV
Catheter Cardiovasc Interv; 2020 May; 95(6):1212-1218. PubMed ID: 31566892
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy.
Fortunato de Cano S; Nicolas Cano M; de Ribamar Costa J; Alves Pinheiro J; Bellio de Mattos Barretto R; Costa de Souza Le Bihan D; Abizaid A; Sousa A; Eduardo Sousa J
Catheter Cardiovasc Interv; 2016 Nov; 88(6):953-960. PubMed ID: 27143093
[TBL] [Abstract][Full Text] [Related]
14. Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy.
Veselka J; Faber L; Liebregts M; Cooper R; Januska J; Kashtanov M; Dabrowski M; Hansen PR; Seggewiss H; Bonaventura J; Polakova E; Hansvenclova E; Bundgaard H; Ten Berg J; Stables RH; Jarkovsky J; Jensen MK
Int J Cardiol; 2021 Jun; 333():127-132. PubMed ID: 33647367
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry.
Veselka J; Jensen MK; Liebregts M; Januska J; Krejci J; Bartel T; Dabrowski M; Hansen PR; Almaas VM; Seggewiss H; Horstkotte D; Tomasov P; Adlova R; Bundgaard H; Steggerda R; Ten Berg J; Faber L
Eur Heart J; 2016 May; 37(19):1517-23. PubMed ID: 26746632
[TBL] [Abstract][Full Text] [Related]
16. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
17. Alcohol-induced right bundle branch block is associated with a benign outcome in HOCM after alcohol septum ablation (ASA).
Lawin D; Lawrenz T; Radke K; Wolff A; Stellbrink C
Clin Res Cardiol; 2022 Feb; 111(2):175-185. PubMed ID: 33772362
[TBL] [Abstract][Full Text] [Related]
18. Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry.
Veselka J; Faber L; Liebregts M; Cooper R; Januska J; Krejci J; Bartel T; Dabrowski M; Hansen PR; Almaas VM; Seggewiss H; Horstkotte D; Adlova R; Bundgaard H; Ten Berg J; Stables RH; Jensen MK
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512112
[TBL] [Abstract][Full Text] [Related]
19. Procedural complication and long term outcomes after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: data from China.
An SY; Yang YJ; Hang F; Wang ZM; Fan CM
Sci Rep; 2017 Aug; 7(1):9506. PubMed ID: 28842653
[TBL] [Abstract][Full Text] [Related]
20. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort.
Nguyen A; Schaff HV; Hang D; Nishimura RA; Geske JB; Dearani JA; Lahr BD; Ommen SR
J Thorac Cardiovasc Surg; 2019 Jan; 157(1):306-315.e3. PubMed ID: 30279000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
